Sofosbuvir‐Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real‐life experience from the HEPATHER ANRS CO22 cohort

2020 ◽  
Vol 27 (10) ◽  
pp. 964-973
Author(s):  
Victor Lédinghen ◽  
Clovis Lusivika‐Nzinga ◽  
Jean‐Pierre Bronowicki ◽  
Fabien Zoulim ◽  
Dominique Larrey ◽  
...  
2015 ◽  
Vol 148 (4) ◽  
pp. S-1092 ◽  
Author(s):  
Oliver N. Lin ◽  
Nghia Nguyen ◽  
Christine Y. Chang ◽  
Alina Kutsenko ◽  
Aijaz Ahmed ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document